LENSAR, Inc.
LNSRLENSAR is a commercial-stage medical device company specializing in advanced femtosecond laser systems for cataract surgery and the management of corneal astigmatism.
Earnings
Next report
Nov 12, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
LENSAR is a commercial-stage medical device company specializing in advanced femtosecond laser systems for cataract surgery and the management of corneal astigmatism. The company provides robotic surgical solutions that integrate high-resolution imaging and artificial intelligence to automate critical steps of the procedure, aiming to improve visual outcomes and surgical efficiency. Its value proposition centers on enabling surgeons to transition to premium, patient-pay refractive procedures through enhanced precision and streamlined operating room workflows.
A specialized challenger in the femtosecond laser market, distinguished by the ALLY System's dual-modality laser and small footprint designed for single-room sterile surgery.
FAQ
- What is LENSAR, Inc.'s market cap?
- LENSAR, Inc. (LNSR) has a market capitalization of $87.0M and trades on NASDAQ.
- What is LENSAR, Inc.'s revenue and profitability?
- LENSAR, Inc. generated $60.3M in trailing twelve-month revenue with net income of $34.7M, representing a net margin of 57.6%. Gross margin stands at 48.3%. The latest reported period is Q2 2026.
- Who are LENSAR, Inc.'s competitors?
- LENSAR, Inc.'s key competitors include STAAR Surgical, Bausch + Lomb, Alcon Inc., and others. These companies compete in similar markets and product categories.
- Where is LENSAR, Inc. headquartered?
- LENSAR, Inc. is headquartered in United States of America and employs approximately 130 people. It has been publicly traded since 2020.
